MetLife, Inc.

New York Stock Exchange
Somewhat Bullish +35

MetLife (MET) Stock May Be 44% Below Fair Value On Returns - simplywall.st

📈 MetLife stock has generated an 80.7% total return for investors over the past five years.

💰 An Excess Returns model estimates a fair value of $169.91 per share, implying a 44% discount to current pricing.

📊 The company projects a stable book value of $53.18 per share with an average return on equity of 15.83%.

⚖️ MetLife trades at a P/E ratio of 17.6x, which is above the industry average of 11.2x and peer average of 14.6x.

📉 Broader valuation checks assign MetLife a low value score of 2 out of 6, indicating it may not be a clear bargain on traditional metrics.

🔮 The stock's future performance depends on maintaining returns on equity that exceed its cost of capital to justify the intrinsic value case.

Bullish Signals
  • MetLife appears undervalued by 44.0% according to an Excess Returns intrinsic value model based on projected cash generation.
  • The company is expected to generate a stable book value of $53.18 per share, supporting a high return on equity profile.
Risk Factors
  • MetLife trades at a P/E ratio of 17.6x, which is significantly above the broader insurance industry average of 11.2x and peer group average of 14.6x.
  • Broader valuation checks assign the stock a low value score of 2 out of 6, suggesting it may not be a clear bargain on traditional metrics.
Full Analysis
MetLife (MET) stock has delivered an 80.7% total return over the past five years, yet valuation models present a mixed picture regarding future upside. While earnings multiples appear reasonable, broader checks suggest the stock is not a clear bargain based on current metrics. Using an Excess Returns intrinsic value model, MetLife appears undervalued by approximately 44%. The analysis projects a stable book value of $53.18 per share and a cost of equity of $3.99, resulting in an excess return of $4.43 per share that supports a fair value estimate of $169.91. Conversely, traditional valuation metrics indicate the stock is roughly fairly valued with only a modest premium. MetLife currently trades at a P/E ratio of 17.6x, which is higher than the broader insurance industry average of 11.2x and the peer group average of 14.6x, suggesting the market has already priced in some of its strengths.